- Buyouts
- Expansion
- Early stage
- Turnaround
- Exits
- Portfolio management
- Infrastructure
- Cleantech
- Private Equity Insight
- Performance
- Buyout
- Venture
- Mezzanine
- Funds of funds
- Secondaries
- Turnaround/Special Situations
- Cleantech
- Analysis
- Digital Editions
- Reports
- Barometers
- Books
- Private Equity Insight
- Performance
- LP
- People
- Consulting
- Media Centre
- unquote” Jobs
Where am I? 
Home 
Life science partners
Life science partners
New Enterprise and Gimv in €23m round for Prosena
Prosena has secured €23m of new equity financing from New Enterprise Associates (NEA) and existing investors, including Gimv.
Update: Ysios-backed Cellerix and TiGenix complete merger
Cellerix, a Spanish biopharma backed by venture capital investors, and Belgium-based TiGenix, have completed their merger by means of a share-for-share exchange.
Consortium invest £16.9m in Atlas Genetics
A consortium, led by Novartis Venture and Consort Medical, has invested £16.9m in diagnostic company Atlas Genetics Ltd.
LSP et al. invest €8.1m in Mendor
A consortium, consisting of Life Sciences Partners (LSP), Finnish entrepreneur Risto Siilasmaa, Finnish Industry Investment, Ilmarinen Mutual Pension Insurance Company, Biothom and Finnvera...
Consortium injects €13m into Sapiens
A consortium co-led by Wellington Partners and Edmond de Rothschild Investment Partners (EdRIP) has invested €13m in medical device company Sapiens Steering Brain Stimulation GmbH.
CD-Venture et al. invest in Curetis
CD-Venture has joined existing investors LSP Life Sciences Partners, BioMedInvest and KfW in a series-A financing round currently worth €24.5m.
Life Sciences Partners launches €250m fund
Life Sciences Partners has launched LSP Life Sciences Fund N.V. with a target of €250m.
Life Sciences Partners backs Activaero
Venture Capital firm Life Sciences Partners has led a €5m series-A finance round for Activaero.
Ysios et al. invest €18m in Cellerix
Existing investors have invested a further €18m in Spanish biopharma Cellerix, prior to its merger with Belgium-based TiGenix.
Lundbeckfond Ventures et al. invest €11.4m in Nexstim
A consortium of investors led by new investor Lundbeckfond Ventures has invested €11.4m in Finnish medical equipment company Nexstim.
Lundbeckfond Ventures et al. invest €11.4m in Nexstim
A consortium of investors led by Lundbeckfond Ventures has invested €11.4m in Finnish medical equipment company Nexstim.
Consortium lists Zealand Pharma
A consortium consisting of Sunstone Capital, CDC Innovation Funds, IDInvest Partners, and Life Science Partners, among others, have listed biopharmaceutical company Zealand Pharma A/S...
Seventure et al. raise £18m for Syntaxin
Seventure and Lundbeckfonden have backed a series-C round of funding for life sciences company Syntaxin.
Syntaxin receives £18m investment
Lundbeckfond Ventures, Seventure and Ipsen have taken part in a series-C round of financing for biopharmaceutical company Syntaxin.
Consortium set to list Zealand Pharma
A consortium, consisting of Life Sciences Partners and Sunstone Capital among others, has announced its intention to list Zealand Pharma A/S on the NASDAQ OMX Copenhagen.
Regions
Search unquote.com
Events
unquote" CEE Private Equity Congress
Now in its 6th consecutive year, Unquote" is proud to announce the date for our annual Central...
Updating your subscription status 
Regions - click map below to view
Digital Editions
Reports & statistics
Private Equity jobs
